Chaperone-mediated autophagy: the Achilles heel of the retinal pigment epithelium during age-related macular degeneration

Mar 4, 2026Autophagy

Chaperone-mediated autophagy as a key weakness in the eye’s support cells during age-related macular degeneration

AI simplified

Longevity & Aging on OpenScience ↗PubMed ↗DOI ↗OA ↗

Abstract

Chaperone-mediated autophagy (CMA) is selectively impaired in the retinal pigment epithelium (RPE) of age-related macular degeneration (AMD) patients compared to healthy donors.

CMA decreases with physiological aging and its impairment is linked to age-related diseases.
In AMD, the RPE shows significant morphological and functional alterations early in the disease process.
Impaired CMA in AMD leads to the buildup of undegraded proteins and disrupted recycling of other proteins.
Dysfunctional CMA is associated with increased proteotoxicity, oxidative damage, and altered metabolism in AMD.
Restoration of CMA using the activator CA77.1 improves proteostasis in AMD patient-derived iPSC-RPE models.

AI simplified

Chaperone-mediated autophagy (CMA) is a selective autophagy pathway that targets specific proteins containing a KFERQ-like motif for lysosomal degradation. It has been shown by us and others that CMA decreases during physiological aging in most tissues, and its impairment is associated with increased incidence of age-related pathologies, such as cardiovascular disease, neurodegenerative disorders or sarcopenia. However, its involvement in age-related macular degeneration (AMD), a prevalent progressive maculopathy that leads to bilateral central vision loss, had not been explored. In the early stages of AMD, the retinal pigment epithelium (RPE), a monolayer of cells that provides trophic support to photoreceptors, already presents major morphological and functional alterations but the cause of this cell type-specific vulnerability is unknown. In our latest work, we analyzed human donor RPE samples and found that CMA is selectively impaired in the RPE of AMD patients compared to healthy donors. These alterations lead to the accumulation of undegraded CMA substrates and untimely recycling of other proteins. Crucially, these findings are conserved in donor-derived iPSC-RPE models. We used this clinically relevant model to assess the consequences of dysfunctional CMA in AMD and found that it caused proteotoxicity, increased oxidative damage, and altered metabolism. Most importantly, using the new-generation CMA activator CA77.1, we restored proteostasis in AMD iPSC-RPE. Our findings shed light on the selective vulnerability of the RPE in AMD and provide evidence in support of CMA as a novel druggable target against AMD.

Full Text

Full text is available at the source.

View full text ↗

Chaperone-mediated autophagy: the Achilles heel of the retinal pigment epithelium during age-related macular degeneration

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the longevity & aging brief

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the longevity & aging brief